Algeria vs Serbia: Cause of death, by non-communicable diseases, ages 15-59, female
Algeria
70.8%
in 2021
Serbia
70.3%
in 2021
Algeria rank
54th
Serbia rank
57th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Algeria
- Serbia
How they compare
Algeria currently reports 70.8% against 70.3% in Serbia, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Serbia ahead.
Algeria ranks 54th and Serbia ranks 57th of 185 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.7% | 88.5% | 18.8% | Serbia |
| 2010s | 74.8% | 90.6% | 15.8% | Serbia |
| 2020s | 64.2% | 75.9% | 11.7% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Algeria or Serbia?
- Algeria, at 70.8% against 70.3% in Serbia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Algeria and Serbia?
- 0.5%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Serbia rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Algeria ranks 54th and Serbia ranks 57th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.